Welcome to Multibagg AI
Log in to access personalized features
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
198.00 | 187 Cr | 36.53 | 5.12 | 0.00 | 14.23 | 14.41 | 6.62 | |
8.85 | 136 Cr | 15.24 | 2.90 | 0.00 | 19.50 | 15.11 | 11.12 | |
88.85 | 116 Cr | -2961.67 | 13.83 | 0.00 | -2.77 | -2.77 | -2.70 | |
70.00 | 75 Cr | 7.23 | 1.62 | 0.00 | 17.40 | 19.17 | 8.03 | |
114.00 | 68 Cr | 26.76 | 2.34 | 1.32 | 7.12 | 9.80 | 6.37 | |
51.50 | 53 Cr | 7.84 | 1.61 | 0.00 | 29.37 | 38.86 | 10.85 | |
7.15 | 39 Cr | 4.74 | 0.96 | 0.00 | 13.76 | 11.82 | 2.38 |
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Genesis IBRC India Ltd (GENESIS) is currently trading at 93.22 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Genesis IBRC India Ltd, originally Fine Plast Polymers Ltd, primarily manufactures rigid PVC pipes and fittings, catering largely to agriculture and industry applications. Throughout its history, Genesis IBRC India Ltd has experienced multiple name changes and strategic shifts, including a venture into lifestyle products and probiotic manufacturing. Genesis IBRC, at one point, owned a subsidiary focused on probiotic products, but later sold its stakes in that subsidiary, signaling a refocus on core operations. The company's historical struggle with working capital issues highlights its challenges in maintaining operational efficiency and profitability. Genesis IBRC India Ltd has a notable history of collaboration with consultancies and exploring joint ventures, showcasing strategic attempts to expand its market reach.
Over the past 52 weeks, Genesis IBRC India Ltd has traded between a low of ₹18.34 and a high of ₹184.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Genesis IBRC India Ltd has a market capitalization of approximately 115.51. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Genesis IBRC India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -3107.33 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 115.51 Cr, Genesis IBRC India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Genesis IBRC India Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Genesis IBRC India Ltd is -3107.33. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
7
Neutral
2
Bullish
5
Bearish
9
Neutral
10
Bullish
27
Bearish
2
Neutral
8
Bullish
22
Postal Ballot Results
Genesis IBRC India Ltd. (Scrip: 514336, ISIN: INE194N01016) informs that shareholders, via remote e-voting completed on 5 Mar 2026, approved all postal ballot resolutions including a special resolution to change the company name; scrutinizer: Piyush A. Gohel.
Postal Ballot Outcome
Shareholders approved on Mar 5, 2026 the change of name to CCME Global Limited, alteration of the main object clause to add FMCG/commodities/minerals business, increase in authorised capital, preferential issue and multiple director appointments.
Postal Ballot Outcome
Via postal ballot (concluded Mar 5, 2026) shareholders approved change of name to CCME Global Limited, alteration of main object to include FMCG, commodities & minerals, increase in authorised capital, preferential issue and multiple director appointments.
Postal Ballot Outcome
Shareholders (postal ballot concluded 5 Mar 2026) approved changing the name to CCME Global Limited, broadening MoA to include FMCG/commodities/minerals, increasing authorised capital, preferential issue and multiple director appointments.
Postal Ballot Outcome
Shareholders (postal ballot concluded 5 Mar 2026) approved changing the name to CCME Global Limited, broadening the MoA main object to include FMCG/commodities/minerals, increasing authorised capital, a preferential equity issue and multiple director/KMP appointments including MD.
Postal Ballot Outcome
Shareholders (postal ballot concluded 5 Mar 2026) approved change of name to CCME Global Limited, alteration of main objects to include FMCG/commodities/minerals, increase in authorised capital, preferential equity issue and multiple director appointments (including MD and Chair).
Genesis IBRC India Ltd, originally Fine Plast Polymers Ltd, primarily manufactures rigid PVC pipes and fittings, catering largely to agriculture and industry applications.
Throughout its history, Genesis IBRC India Ltd has experienced multiple name changes and strategic shifts, including a venture into lifestyle products and probiotic manufacturing.
Genesis IBRC, at one point, owned a subsidiary focused on probiotic products, but later sold its stakes in that subsidiary, signaling a refocus on core operations.
The company's historical struggle with working capital issues highlights its challenges in maintaining operational efficiency and profitability.
Genesis IBRC India Ltd has a notable history of collaboration with consultancies and exploring joint ventures, showcasing strategic attempts to expand its market reach.
Healthcare
Plastics - Pipes
116 Cr
Low Risk
-3,107.3
56.6
—
13.8
184.90
18.34
Sales CAGR
Profit CAGR
ROE
ROCE
